Evidence map›Paper›PMID 42615702›Full record

ArticleRevista brasileira de epidemiologia = Brazilian journal of epidemiology2026

COVID-19 vaccine effectiveness against in-hospital mortality in immunocompromised older adults: a Brazilian hospital surveillance study, 2024.

Rodrigo Poubel Vieira de Rezende, João Felipe Nicolaci Pimentel, Bruno Santos Caxias, Caio Moreira Salgueiro, Lucas Tanikawa de Oliveira, Luís Fernando de Araújo Santos, Caroline Pimentel Pessanha, Vitoria Xavier Tracierra, Michael Gunter Simão, Mario Gustavo de Aranda Pacheco and 2 more

Abstract read
In one paragraph

Article in Revista brasileira de epidemiologia = Brazilian journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rodrigo Poubel Vieira de RezendeUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0000-0002-1623-259X
João Felipe Nicolaci PimentelUniversidade Federal Fluminense, Institute of Computing - Niterói (RJ), Brazil.ORCID http://orcid.org/0000-0001-6680-7470
Bruno Santos CaxiasUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0006-3091-1472
Caio Moreira SalgueiroUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0007-5939-201X
Lucas Tanikawa de OliveiraUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0009-0386-9151
Luís Fernando de Araújo SantosUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0007-8337-6095
Caroline Pimentel PessanhaUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0006-9327-1898
Vitoria Xavier TracierraUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0005-6486-8380
Michael Gunter SimãoUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0006-8581-4960
Mario Gustavo de Aranda PachecoUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0002-7032-912X
Vitor Alves CruzUniversidade Federal de Goiás, Faculty of Medicine - Goiânia (GO), Brazil.ORCID http://orcid.org/0000-0002-3073-2929
Luiz Eduardo da Costa OliveiraUniversidade Federal Fluminense, Faculty of Medicine - Niterói (RJ), Brazil.ORCID http://orcid.org/0009-0009-2814-8318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study evaluated the association between COVID-19 vaccination and in-hospital mortality among immunocompromised older adults hospitalized for COVID-19 in Brazil during the 2024 epidemiologic year.

methodsThis retrospective hospital-based surveillance study used data from the Brazilian SIVEP-Gripe database. All hospitalized cases of COVID-19-related severe acute respiratory syndrome in immunocompromised individuals aged ≥60 years reported during epidemiological weeks 1-52 of 2024 were included. Multivariable logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (95%CI) for the association between COVID-19 vaccination (number of doses) and in-hospital mortality, adjusting for clinical and sociodemographic covariates.

resultsAmong 474 patients, in-hospital mortality was 36% (171/474). Only 56 (12%) were unvaccinated. Compared with unvaccinated individuals, adjusted ORs for mortality were 0.67 (95%CI 0.32-1.39) for 1-2 doses, 0.67 (95%CI 0.31-1.42) for 3 doses, 0.54 (95%CI 0.26-1.15) for 4 doses, and 0.56 (95%CI 0.26-1.17) for 5-6 doses. Mechanical ventilation (OR 12.55; 95%CI 6.39-26.33) and lower educational attainment (elementary education: OR 2.94; 95%CI 1.39-6.44) were independent predictors of death. COVID-19 vaccination was not significantly associated with reduced in-hospital mortality among immunocompromised older adults hospitalized for the disease in Brazil in 2024. However, all adjusted ORs were below unity, suggesting a trend toward protection with increasing doses.

conclusionsThe strong association of mortality with mechanical ventilation and social determinants highlights the need for timely boosters and comprehensive preventive strategies for this vulnerable population.

Indexed as

COVID-19COVID-19 VaccinesHospital MortalityImmunocompromised HostVaccine EfficacyAgedAged, 80 and overBrazilFemaleHospitalizationHumansMaleMiddle AgedRetrospective StudiesUnvaccinated PersonsCOVID-19 Vaccines

Identifiers

PMID42615702
PMCPMC13480620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.